125 related articles for article (PubMed ID: 35088378)
1. SHOX2 methylation in Vietnamese patients with lung cancer.
Vo TTL; Nguyen TN; Nguyen TT; Pham ATD; Vuong DL; Ta VT; Ho VS
Mol Biol Rep; 2022 May; 49(5):3413-3421. PubMed ID: 35088378
[TBL] [Abstract][Full Text] [Related]
2. A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.
Huang W; Huang H; Zhang S; Wang X; Ouyang J; Lin Z; Chen P
Cancer Control; 2020; 27(1):1073274820969703. PubMed ID: 33167712
[TBL] [Abstract][Full Text] [Related]
3. The performance of the
Xu Z; Wang Y; Wang L; Xiong J; Wang H; Cui F; Peng H
Biomark Med; 2020 Apr; 14(5):341-351. PubMed ID: 32250153
[No Abstract] [Full Text] [Related]
4. Quantification of cell-free mSHOX2 Plasma DNA for therapy monitoring in advanced stage non-small cell (NSCLC) and small-cell lung cancer (SCLC) patients.
Schmidt B; Beyer J; Dietrich D; Bork I; Liebenberg V; Fleischhacker M
PLoS One; 2015; 10(2):e0118195. PubMed ID: 25675432
[TBL] [Abstract][Full Text] [Related]
5. Validation of the SHOX2/PTGER4 DNA Methylation Marker Panel for Plasma-Based Discrimination between Patients with Malignant and Nonmalignant Lung Disease.
Weiss G; Schlegel A; Kottwitz D; König T; Tetzner R
J Thorac Oncol; 2017 Jan; 12(1):77-84. PubMed ID: 27544059
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the comprehensive diagnosis efficiency of lung cancer, including measurement of SHOX2 and RASSF1A gene methylation.
Liu J; Bian T; She B; Liu L; Sun H; Zhang Q; Zhu J; Zhang J; Liu Y
BMC Cancer; 2024 Mar; 24(1):282. PubMed ID: 38429660
[TBL] [Abstract][Full Text] [Related]
7. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma.
Kneip C; Schmidt B; Seegebarth A; Weickmann S; Fleischhacker M; Liebenberg V; Field JK; Dietrich D
J Thorac Oncol; 2011 Oct; 6(10):1632-8. PubMed ID: 21694641
[TBL] [Abstract][Full Text] [Related]
8. The value of SHOX2 methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and other lung disorders.
Konecny M; Markus J; Waczulikova I; Dolesova L; Kozlova R; Repiska V; Novosadova H; Majer I
Neoplasma; 2016; 63(2):246-53. PubMed ID: 26774146
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of RASSF1A and SHOX2 methylation combined with EGFR mutations for differentiation between small pulmonary nodules.
Ji XY; Li H; Chen HH; Lin J
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8557-8571. PubMed ID: 37097393
[TBL] [Abstract][Full Text] [Related]
10. Monitoring of lung malignant epithelial cells by gene methylation analysis in the conditionally reprogrammed cell cultures.
Wu GD; Xiao YG; Fang FY; Yao D; Liu J; Cao YH; Mao Y; Yu B; Yao TR; Wu YM; Qian YH; Yu DH
Neoplasma; 2020 May; 67(3):692-699. PubMed ID: 32202907
[TBL] [Abstract][Full Text] [Related]
11. miR-375 Combined with SHOX2 Methylation has Higher Diagnostic Efficacy for Non-Small-Cell Lung Cancer.
Zeng S; Lin C; Huang Y
Mol Biotechnol; 2023 Jul; 65(7):1187-1197. PubMed ID: 36462101
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients.
Dietrich D; Hasinger O; Liebenberg V; Field JK; Kristiansen G; Soltermann A
Diagn Mol Pathol; 2012 Jun; 21(2):93-104. PubMed ID: 22555092
[TBL] [Abstract][Full Text] [Related]
13. Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors.
Schneider KU; Dietrich D; Fleischhacker M; Leschber G; Merk J; Schäper F; Stapert HR; Vossenaar ER; Weickmann S; Liebenberg V; Kneip C; Seegebarth A; Erdogan F; Rappold G; Schmidt B
BMC Cancer; 2011 Mar; 11():102. PubMed ID: 21426551
[TBL] [Abstract][Full Text] [Related]
14. An Internal Control for Evaluating Bisulfite Conversion in the Analysis of Short Stature Homeobox 2 Methylation in Lung Cancer.
Lan VTT; Trang VL; Ngan NT; Son HV; Toan NL
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2435-2443. PubMed ID: 31450918
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of SHOX2 promoter methylation as biomarker for lung cancer identification: A meta-analysis update.
Zhou X; Lu X; Wu H; Liu J; Huang H
Thorac Cancer; 2021 Dec; 12(24):3327-3332. PubMed ID: 34741433
[TBL] [Abstract][Full Text] [Related]
16. The
Peng X; Liu X; Xu L; Li Y; Wang H; Song L; Xiao W
J Thorac Dis; 2019 Jun; 11(6):2458-2469. PubMed ID: 31372283
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic Efficacy of SHOX2 Gene Hypermethylation for Lung Cancer: A Meta-Analysis].
Liu Q; Wang S; Pei G; Yang Y; Huang Y
Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):490-496. PubMed ID: 34275516
[TBL] [Abstract][Full Text] [Related]
18. Performance of SHOX2 and RASSF1A methylation assay in supernatants and matched cell pellets for the diagnosis of malignant pleural effusion.
Zhang N; Li Y; Zhang H; Dong Y; Zhang C; Du W; Long C; Xing X; Li K; Liu Z; Chen X; Zhang L; Xu F; Fu Y; Tan J; She B; Che N
Clin Chim Acta; 2024 Jan; 553():117699. PubMed ID: 38072300
[TBL] [Abstract][Full Text] [Related]
19. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates.
Schmidt B; Liebenberg V; Dietrich D; Schlegel T; Kneip C; Seegebarth A; Flemming N; Seemann S; Distler J; Lewin J; Tetzner R; Weickmann S; Wille U; Liloglou T; Raji O; Walshaw M; Fleischhacker M; Witt C; Field JK
BMC Cancer; 2010 Nov; 10():600. PubMed ID: 21047392
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.
Dietrich D; Jung M; Puetzer S; Leisse A; Holmes EE; Meller S; Uhl B; Schatz P; Ivascu C; Kristiansen G
PLoS One; 2013; 8(12):e84225. PubMed ID: 24386354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
